Clinical Trials Browser

Phase 2 × Unknown × Dermatitis × Clear all

NCT02580279 2019-04-05

Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy

Phase 2 Unknown

Breast Neoplasms, Dermatitis